Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
Maju Mathew Koola, Douglas Lee Boggs, Deanna Lynn Kelly, Fang Liu, Jared Allen Linthicum, Hailey Elaine Turner, Robert Patrick McMahon, David Alan Gorelic. Relief of cannabis withdrawal symptoms and cannabis quitting strategies in people with schizophrenia. Psychiatry research. vol 209. issue 3. 2014-05-30. PMID:23969281. |
actions to relieve cannabis withdrawal symptoms in people with schizophrenia are common. |
2014-05-30 |
2023-08-12 |
human |
Berend Malchow, Alkomiet Hasan, Thomas Schneider-Axmann, Alexander Jatzko, Oliver Gruber, Andrea Schmitt, Peter Falkai, Thomas Wobroc. Effects of cannabis and familial loading on subcortical brain volumes in first-episode schizophrenia. European archives of psychiatry and clinical neuroscience. vol 263 Suppl 2. 2014-05-29. PMID:24085610. |
effects of cannabis and familial loading on subcortical brain volumes in first-episode schizophrenia. |
2014-05-29 |
2023-08-12 |
human |
Berend Malchow, Alkomiet Hasan, Thomas Schneider-Axmann, Alexander Jatzko, Oliver Gruber, Andrea Schmitt, Peter Falkai, Thomas Wobroc. Effects of cannabis and familial loading on subcortical brain volumes in first-episode schizophrenia. European archives of psychiatry and clinical neuroscience. vol 263 Suppl 2. 2014-05-29. PMID:24085610. |
schizophrenia is a severe neuropsychiatric disorder with familial loading as heritable risk factor and cannabis abuse as the most relevant environmental risk factor up to date. |
2014-05-29 |
2023-08-12 |
human |
Berend Malchow, Alkomiet Hasan, Thomas Schneider-Axmann, Alexander Jatzko, Oliver Gruber, Andrea Schmitt, Peter Falkai, Thomas Wobroc. Effects of cannabis and familial loading on subcortical brain volumes in first-episode schizophrenia. European archives of psychiatry and clinical neuroscience. vol 263 Suppl 2. 2014-05-29. PMID:24085610. |
in this magnetic resonance imaging (mri) study in 47 first-episode schizophrenia patients and 30 healthy control subjects, we investigated effects of previous cannabis abuse and increased familial risk on subcortical brain regions such as hippocampus, amygdala, caudate nucleus, putamen, thalamus and subsegments of the corpus callosum (cc). |
2014-05-29 |
2023-08-12 |
human |
Berend Malchow, Alkomiet Hasan, Thomas Schneider-Axmann, Alexander Jatzko, Oliver Gruber, Andrea Schmitt, Peter Falkai, Thomas Wobroc. Effects of cannabis and familial loading on subcortical brain volumes in first-episode schizophrenia. European archives of psychiatry and clinical neuroscience. vol 263 Suppl 2. 2014-05-29. PMID:24085610. |
patients with a family history of schizophrenia combined with previous cannabis abuse showed lower volumes of the bilateral caudate nucleus compared to all other patients, implicating an interaction between the genetic background and cannabis abuse as environmental factor. |
2014-05-29 |
2023-08-12 |
human |
Berend Malchow, Alkomiet Hasan, Thomas Schneider-Axmann, Alexander Jatzko, Oliver Gruber, Andrea Schmitt, Peter Falkai, Thomas Wobroc. Effects of cannabis and familial loading on subcortical brain volumes in first-episode schizophrenia. European archives of psychiatry and clinical neuroscience. vol 263 Suppl 2. 2014-05-29. PMID:24085610. |
future longitudinal studies in first-episode patients with quantification of cannabis abuse and assessment of schizophrenia risk genes are warranted. |
2014-05-29 |
2023-08-12 |
human |
Robin M Murray, Alessandra Paparelli, Paul D Morrison, Arianna Marconi, Marta Di Fort. What can we learn about schizophrenia from studying the human model, drug-induced psychosis? American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. vol 162B. issue 7. 2014-05-27. PMID:24132898. |
research into the effects of lsd initiated the serotonergic model; amphetamines the dopamine hypothesis, pcp and ketamine the glutamatergic hypothesis, while most recently the effects of cannabis have provoked interest in the role of endocannabinoids in schizophrenia. |
2014-05-27 |
2023-08-12 |
human |
Philip Seema. Schizophrenia and dopamine receptors. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 23. issue 9. 2014-05-01. PMID:23860356. |
the elevation in apparent d2high receptors in vivo in schizophrenia matches the elevation in d2high receptors in vitro in animal models of psychosis, including dopamine-supersensitive animals pretreated with amphetamine, marijuana, or phencyclidine, or animals with gene knockouts in various neurotransmitter pathways, including those for glutamate receptors. |
2014-05-01 |
2023-08-12 |
human |
K A Welch, T W Moorhead, A M McIntosh, D G C Owens, E C Johnstone, S M Lawri. Tensor-based morphometry of cannabis use on brain structure in individuals at elevated genetic risk of schizophrenia. Psychological medicine. vol 43. issue 10. 2014-04-22. PMID:23190458. |
tensor-based morphometry of cannabis use on brain structure in individuals at elevated genetic risk of schizophrenia. |
2014-04-22 |
2023-08-12 |
Not clear |
K A Welch, T W Moorhead, A M McIntosh, D G C Owens, E C Johnstone, S M Lawri. Tensor-based morphometry of cannabis use on brain structure in individuals at elevated genetic risk of schizophrenia. Psychological medicine. vol 43. issue 10. 2014-04-22. PMID:23190458. |
cannabis use increases the risk of schizophrenia but reports of brain structural abnormalities in the cannabis-using population have not been consistent. |
2014-04-22 |
2023-08-12 |
Not clear |
K A Welch, T W Moorhead, A M McIntosh, D G C Owens, E C Johnstone, S M Lawri. Tensor-based morphometry of cannabis use on brain structure in individuals at elevated genetic risk of schizophrenia. Psychological medicine. vol 43. issue 10. 2014-04-22. PMID:23190458. |
we used automated image analysis to compare brain structural changes over time in people at elevated risk of schizophrenia for familial reasons who did and did not use cannabis. |
2014-04-22 |
2023-08-12 |
Not clear |
Emilio Fernandez-Egea, Linda Scoriels, Swathi Theegala, Maria Giro, Susan E Ozanne, Keith Burling, Peter B Jone. Cannabis use is associated with increased CCL11 plasma levels in young healthy volunteers. Progress in neuro-psychopharmacology & biological psychiatry. vol 46. 2014-04-22. PMID:23820464. |
increased ccl11 chemokine has been reported in schizophrenia and cannabis is a known trigger of schizophrenia. |
2014-04-22 |
2023-08-12 |
human |
Josiane Bourque, Adrianna Mendrek, Myriam Durand, Nadia Lakis, Olivier Lipp, Emmanuel Stip, Pierre Lalonde, Sylvain Grignon, Stéphane Potvi. Cannabis abuse is associated with better emotional memory in schizophrenia: a functional magnetic resonance imaging study. Psychiatry research. vol 214. issue 1. 2014-04-08. PMID:23906663. |
cannabis abuse is associated with better emotional memory in schizophrenia: a functional magnetic resonance imaging study. |
2014-04-08 |
2023-08-12 |
human |
Josiane Bourque, Adrianna Mendrek, Myriam Durand, Nadia Lakis, Olivier Lipp, Emmanuel Stip, Pierre Lalonde, Sylvain Grignon, Stéphane Potvi. Cannabis abuse is associated with better emotional memory in schizophrenia: a functional magnetic resonance imaging study. Psychiatry research. vol 214. issue 1. 2014-04-08. PMID:23906663. |
in schizophrenia cannabis abuse/dependence is associated with poor compliance and psychotic relapse. |
2014-04-08 |
2023-08-12 |
human |
Josiane Bourque, Adrianna Mendrek, Myriam Durand, Nadia Lakis, Olivier Lipp, Emmanuel Stip, Pierre Lalonde, Sylvain Grignon, Stéphane Potvi. Cannabis abuse is associated with better emotional memory in schizophrenia: a functional magnetic resonance imaging study. Psychiatry research. vol 214. issue 1. 2014-04-08. PMID:23906663. |
accordingly, we performed a functional magnetic resonance imaging study of emotional memory in schizophrenia patients with cannabis abuse (dual-diagnosis, dd). |
2014-04-08 |
2023-08-12 |
human |
Josiane Bourque, Adrianna Mendrek, Myriam Durand, Nadia Lakis, Olivier Lipp, Emmanuel Stip, Pierre Lalonde, Sylvain Grignon, Stéphane Potvi. Cannabis abuse is associated with better emotional memory in schizophrenia: a functional magnetic resonance imaging study. Psychiatry research. vol 214. issue 1. 2014-04-08. PMID:23906663. |
these results are consistent with previous findings showing that cannabis abuse is associated with fewer negative symptoms and better cognitive functioning in schizophrenia. |
2014-04-08 |
2023-08-12 |
human |
Josiane Bourque, Adrianna Mendrek, Myriam Durand, Nadia Lakis, Olivier Lipp, Emmanuel Stip, Pierre Lalonde, Sylvain Grignon, Stéphane Potvi. Cannabis abuse is associated with better emotional memory in schizophrenia: a functional magnetic resonance imaging study. Psychiatry research. vol 214. issue 1. 2014-04-08. PMID:23906663. |
longitudinal studies will need to determine whether the relative preservation of emotional memory is primary or secondary to cannabis abuse in schizophrenia. |
2014-04-08 |
2023-08-12 |
human |
Francisco Arias, Nestor Szerman, Pablo Vega, Beatriz Mesias, Ignacio Basurte, Consuelo Morant, Enriqueta Ochoa, Félix Poyo, Francisco Babi. Abuse or dependence on cannabis and other psychiatric disorders. Madrid study on dual pathology prevalence. Actas espanolas de psiquiatria. vol 41. issue 2. 2014-03-12. PMID:23592072. |
cannabis use has been associated to a wide variety of mental disorders, the possible causal role of this use in the etiology of severe mental disorders as schizophrenia or bipolar disorder standing out. |
2014-03-12 |
2023-08-12 |
Not clear |
Thomas Schnell, Theresa Becker, Maria Chantal Thiel, Euphrosyne Gouzoulis-Mayfran. Craving in patients with schizophrenia and cannabis use disorders. Canadian journal of psychiatry. Revue canadienne de psychiatrie. vol 58. issue 11. 2014-03-10. PMID:24246436. |
craving in patients with schizophrenia and cannabis use disorders. |
2014-03-10 |
2023-08-12 |
human |
Thomas Schnell, Theresa Becker, Maria Chantal Thiel, Euphrosyne Gouzoulis-Mayfran. Craving in patients with schizophrenia and cannabis use disorders. Canadian journal of psychiatry. Revue canadienne de psychiatrie. vol 58. issue 11. 2014-03-10. PMID:24246436. |
cannabis use is widespread among patients with schizophrenia despite its negative impact on the course of the disease. |
2014-03-10 |
2023-08-12 |
human |